Microsoft announced that, starting today, individual Windows developers will no longer have to pay for publishing their applications on the Microsoft Store. Microsoft has resolved severe lag and ...

Microsoft 365 deals and discounts are back! After Microsoft announced a price increase for Microsoft 365 Personal and Microsoft 365 Family, sales on the software suite dried up. Right now, you can ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

Public cloud is widely considered to be the future of enterprise computing, and Azure is a leading service that benefits the evolution to first to hybrid environments, and then ultimately to public ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...